Welcome Guest

Pfizer bolsters cancer portfolio with $10.64 billion deal for Array

reuters | Posted on 2019-06-17 05:35 PM

Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash to beef up its cancer portfolio as it faces rising generic competition for its blockbuster drugs.

Related Articles

  • Live
  • Upcomming
  • Completed